Great to see our research w/ Wellcome Sanger Institute & Cambridge University in Nature Genetics. Our team ID'd new genetic drivers for age-related mutations in blood that may have implications for how we diagnose & treat blood cancers & related myeloproliferative diseases in the future.

We're excited to announce the extension of Calico’s partnership with @BroadInstitute with an added focus on age-related neurodegeneration. We look forward to building on our successful collaboration in the years to come.

Read more: calicolabs.com/press/calico-a…

#aging

For #NationalDNADay , Calico Principal Investigator David Kelley, PhD, shares Calico’s approach to building a machine learning toolkit that maps genetic associations with aging-related diseases to the mechanisms of aging:

Unlocking the mysteries of aging requires collaboration & open dialogue.

At Calico, we believe in the power of sharing scientific research with the community to propel aging research forward.

Explore peer-reviewed publications at:
calicolabs.com/publications

The HEALEY ALS Platform Trial has successfully reached full enrollment for its study of ABBV-CLS-7262, an investigational therapy Calico is developing in collaboration w/ AbbVie. Thanks to the participants, families & clinicians in our clinical studies.
massgeneral.org/neurology/als/…

We are pleased to share that Michael Lenardo M.D., #genetics & molecular #immunology researcher & founder of the NIAID News Clinical Genomics Program, has been appointed Chief Scientific Officer of Calico.

Read more here: calicolabs.com/press/calico-a…

Are you an early-career scientist seeking a distinctive path in aging research?

Apply for a Calico Postdoctoral Fellowship & be part of a team that is committed to pursuing groundbreaking discoveries & scientific innovation.

Learn more: calicolabs.com/postdoctoral-f…

#PostDocJobs

At Calico, we’re all on the same team. Whether you’re in the lab or part of our finance team, you’re an important contributor to our mission – to devise interventions that enable people to lead longer & healthier lives.

Learn more: loom.ly/sUR1NhA

In Nature Communications, our researchers resolved the full-length cryoEM structure and binding affinity of a protein complex associated with the development of HPV-driven cancers. These findings reveal protein-protein interactions vital for this oncogenic driver. loom.ly/UCUKdh4